Generate a tailored SOP for Dr. Jonathan Trujillo. Improve your application with a focused, well-structured draft.
Jonathan Trujillo is an Assistant Professor at the University of Chicago in the Department of Medicine-Hematology and Oncology. He focuses on research involving the tumor cell-intrinsic hypoxia inducible factor (HIF)-1a and HIF-2a pathways and their roles in tumor immune evasion. His research has received funding through multiple grants, including K08CA270394 from the NIH, which supports his work elucidating the mechanisms of immune evasion in relation to hypoxia in tumors. Trujillo has also been involved in studies related to coronavirus infections and T-lymphocyte immunotherapy, highlighting his versatility and breadth of expertise in immunology. Throughout his academic career, he has contributed significantly to the field and collaborated with various researchers on key projects. He serves as a principal investigator on several innovative research initiatives, working to advance the understanding of cancer immunology and therapy.
University of Chicago • Chicago, IL
Works in the Department of Medicine-Hematology and Oncology focusing on research related to tumor immunology.
Department of Philosophy